← Back
$ALLO All transactions

Allogene Therapeutics, Inc.

A

$ Value

$0

Shares

152,480

Price

$0

Filed

Feb 4

Insider

Name

Douglas Earl Martin

Title

SVP, General Counsel

CIK

0001362155

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

152,480

Footnotes

Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.71 to $1.82, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. | 25% of the shares subject to the stock option shall vest on February 2, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter. | Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal annual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date.

Filing Info

Accession No.

0001362155-26-000002

Form Type

4

Issuer CIK

0001737287

Douglas Earl Martin's History

Date Ticker Type Value
2026-02-02 ALLO $40K
2026-02-02 ALLO A $0
2026-02-02 ALLO A $0

Other Insiders at ALLO (90d)

Insider Bought Sold Last
Belldegrun Arie 2026-02-02
Douglas Earl Martin
SVP, General Counsel
$40K 2026-02-02
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
$42K 2026-02-02
Chang David D
President and CEO
$171K 2026-02-02
Yoshiyama Annie
SVP, Finance
$29K 2026-04-21
Roberts Zachary
EVP of R&D
$63K 2026-02-02
Beneski Benjamin Machinas
SVP, Chief Technical Officer
$20K 2026-03-31